Search

Author/Creator Samaras, Christy J.

1. Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma. (28th February 2020)

Authors:
Chakraborty, Rajshekhar; Rybicki, Lisa; Nakashima, Megan O.; Dean, Robert M.; Faiman, Beth M.; Samaras, Christy J.; Rosko, Nathaniel; Dysert, Hayley; Valent, Jason; Anwer, Faiz
Journal:
British journal of haematology
Issue:
Volume 189:Number 6(2020)
Page Start:
1074
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Daratumumab proves safe and highly effective in AL amyloidosis. (25th June 2018)

Authors:
Khouri, Jack; Kin, Andrew; Thapa, Bicky; Reu, Frederic J.; Bumma, Naresh; Samaras, Christy J.; Liu, Hien D.; Karam, Mary A.; Reed, Janice; Mathur, Saveta; Faiman, Beth M.; Devries, Georgia; Zonder, Jeffrey; Valent, Jason
Journal:
British journal of haematology
Issue:
Volume 185:Number 2(2019)
Page Start:
342
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs. (5th January 2023)

Authors:
Dima, Danai; Li, Ang; Granat, Lauren M.; Dhillon, Puneet; Chamseddine, Fatima; Yalamanchali, Anirudh; Mirzai, Saeid; Wei, Wei; Samaras, Christy J.; Valent, Jason; Anwer, Faiz; Khouri, Jack
Journal:
British journal of haematology
Issue:
Volume 201:Number 2(2023)
Page Start:
280
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Patient-reported outcomes in systemic AL amyloidosis with functional assessment of cancer therapy-general (FACT-G) and patient-reported outcomes measurement information system-global health (PROMIS-GH) in a real-world population. Issue 14 (6th December 2019)

Authors:
Chakraborty, Rajshekhar; Rybicki, Lisa; Tomer, Jacqulyn; Samaras, Christy J.; Faiman, Beth M.; Valent, Jason; Majhail, Navneet S.
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 14(2019)
Page Start:
3544
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Progression with clinical features is associated with worse subsequent survival in multiple myeloma. Issue 4 (6th February 2019)

Authors:
Chakraborty, Rajshekhar; Liu, Hien D.; Rybicki, Lisa; Tomer, Jacqulyn; Khouri, Jack; Dean, Robert M.; Faiman, Beth M.; Kalaycio, Matt; Samaras, Christy J.; Majhail, Navneet S.; Valent, Jason
Journal:
American journal of hematology
Issue:
Volume 94:Issue 4(2019:Apr.)
Page Start:
439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study. (17th May 2021)

Authors:
Covut, Fahrettin; Ahmed, Ramsha; Chawla, Sanchit; Ricaurte, Frank; Samaras, Christy J.; Anwer, Faiz; Garcia, Alex V. M.; Angelini, Dana E.; Mazzoni, Sandra; Faiman, Beth; Valent, Jason; Khouri, Jack
Journal:
British journal of haematology
Issue:
Volume 193:Number 6(2021)
Page Start:
1213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗